MARSHALL WACE, LLP

Holdings History for NewAmsterdam Pharma Co N.V. - Ordinary Shares, nominal value EUR0.12 per share (NAMS)

Symbol: NAMS on Nasdaq
Investment type: Equity / Ordinary Shares, nominal value EUR0.12 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Mar 2025		-0.01%	$0	0	-288,446	-100%	$34.28	Q1 2025
31 Dec 2024	0.01%	+0.01%	$7,413,062	288,446	+178,322	+162%	$25.70	Q4 2024
30 Sep 2024	0%	+0%	$1,828,059	110,124	+88,293	+404%	$16.60	Q3 2024
30 Jun 2024	0%	-0%	$419,372	21,831	-93,549	-81%	$19.21	Q2 2024
31 Mar 2024	0%	+0%	$2,728,737	115,380	+81,439	+240%	$23.65	Q1 2024
31 Dec 2023	0%	+0%	$379,120	33,941	+23,777	+234%	$11.17	Q4 2023
30 Sep 2023	0%	-0%	$94,018	10,164	-15,197	-60%	$9.25	Q3 2023
30 Jun 2023	0%	+0%	$301,542	25,361	+25,361	NEW	$11.89	Q2 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.